$5.15 0.21 (+4.25%)
11/27/2009 1:00 PM

Cytori Therapeutics, Inc. (USA) (CYTX)

CAPS Rating: 4 out of 5

A developing company which seeks to commercialize stem and regenerative cell therapies for cardiovascular disease, reconstructive surgery and many other serious, chronic, and life threatening conditions.

Featured Broker Partners